Cancer chemotherapy in urology.
D000230:Adenocarcinoma / Q000188:drug therapy; D000477:Alkylating Agents / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D003035:Cobalt / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004407:Dysgerminoma / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D010212:Papilloma / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013724:Teratoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D013739:Testosterone / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000188:drug therapy
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D002699:Chlorambucil; D003609:Dactinomycin; D003035:Cobalt; D013739:Testosterone; D014750:Vincristine; D013852:Thiotepa; D008525:Medroxyprogesterone; D005472:Fluorouracil